SF3B1 and melanoma: Using a combination of RNA sequencing and qRT-PCR, we identified eight differentially spliced transcripts between mutant SF3B1 and wild-type breast cancers that were also reported to be differentially spliced in SF3B1 mutant melanomas [13], highlighting that this signature is additionally conserved in breast cancer.